These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 25003011)

  • 21. Pharmaceutical Chaperones and Proteostasis Regulators in the Therapy of Lysosomal Storage Disorders: Current Perspective and Future Promises.
    Mohamed FE; Al-Gazali L; Al-Jasmi F; Ali BR
    Front Pharmacol; 2017; 8():448. PubMed ID: 28736525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pressure for drug development in lysosomal storage disorders - a quantitative analysis thirty years beyond the US orphan drug act.
    Mechler K; Mountford WK; Hoffmann GF; Ries M
    Orphanet J Rare Dis; 2015 Apr; 10():46. PubMed ID: 25896727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination Therapies for Lysosomal Storage Diseases: A Complex Answer to a Simple Problem.
    Macauley SL
    Pediatr Endocrinol Rev; 2016 Jun; 13 Suppl 1(Suppl 1):639-48. PubMed ID: 27491211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent advances in gene therapy for lysosomal storage disorders.
    Rastall DP; Amalfitano A
    Appl Clin Genet; 2015; 8():157-69. PubMed ID: 26170711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High proportion of mannosidosis and fucosidosis among lysosomal storage diseases in Cuba.
    Menéndez-Sainz C; González-Quevedo A; González-García S; Peña-Sánchez M; Giugliani R
    Genet Mol Res; 2012 Aug; 11(3):2352-9. PubMed ID: 22911605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of lysosomal storage diseases: recent patents and future strategies.
    Ortolano S; Viéitez I; Navarro C; Spuch C
    Recent Pat Endocr Metab Immune Drug Discov; 2014 Jan; 8(1):9-25. PubMed ID: 24433521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enzyme enhancement therapeutics for lysosomal storage diseases: Current status and perspective.
    Thomas R; Kermode AR
    Mol Genet Metab; 2019 Feb; 126(2):83-97. PubMed ID: 30528228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel biomarkers for lysosomal storage disorders: Metabolomic and proteomic approaches.
    Elmonem MA; Abdelazim AM
    Clin Chim Acta; 2020 Oct; 509():195-209. PubMed ID: 32561345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulatory strategies for rare diseases under current global regulatory statutes: a discussion with stakeholders.
    Mulberg AE; Bucci-Rechtweg C; Giuliano J; Jacoby D; Johnson FK; Liu Q; Marsden D; McGoohan S; Nelson R; Patel N; Romero K; Sinha V; Sitaraman S; Spaltro J; Kessler V
    Orphanet J Rare Dis; 2019 Feb; 14(1):36. PubMed ID: 30736861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Astrocytes and lysosomal storage diseases.
    Rama Rao KV; Kielian T
    Neuroscience; 2016 May; 323():195-206. PubMed ID: 26037807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact, Characterization, and Rescue of Pre-mRNA Splicing Mutations in Lysosomal Storage Disorders.
    Dardis A; Buratti E
    Genes (Basel); 2018 Feb; 9(2):. PubMed ID: 29415500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. From bedside to cell biology: a century of history on lysosomal dysfunction.
    Coutinho MF; Matos L; Alves S
    Gene; 2015 Jan; 555(1):50-8. PubMed ID: 25275857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology and diagnosis of lysosomal storage disorders; challenges of screening.
    Kingma SD; Bodamer OA; Wijburg FA
    Best Pract Res Clin Endocrinol Metab; 2015 Mar; 29(2):145-57. PubMed ID: 25987169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum protein profile analysis in lysosomal storage disorders patients.
    López de Frutos L; García-González E; García-Rodríguez B; González-Irazabal Y; Lahoz C; Irún P; Cebolla JJ; Giraldo P
    Clin Chim Acta; 2020 Nov; 510():430-436. PubMed ID: 32745579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modeling Lysosomal Storage Diseases in the Zebrafish.
    Zhang T; Peterson RT
    Front Mol Biosci; 2020; 7():82. PubMed ID: 32435656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Post-approval Studies for Rare Disease Treatments and Orphan Drugs.
    Maier WC; Christensen RA; Anderson P
    Adv Exp Med Biol; 2017; 1031():197-205. PubMed ID: 29214573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Trials for Gene Therapy in Lysosomal Diseases With CNS Involvement.
    Sevin C; Deiva K
    Front Mol Biosci; 2021; 8():624988. PubMed ID: 34604300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inherited Metabolic Disorders: Efficacy of Enzyme Assays on Dried Blood Spots for the Diagnosis of Lysosomal Storage Disorders.
    Verma J; Thomas DC; Kasper DC; Sharma S; Puri RD; Bijarnia-Mahay S; Mistry PK; Verma IC
    JIMD Rep; 2017; 31():15-27. PubMed ID: 27008195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emptying the stores: lysosomal diseases and therapeutic strategies.
    Platt FM
    Nat Rev Drug Discov; 2018 Feb; 17(2):133-150. PubMed ID: 29147032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.